MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
4578

4578.T

Otsuka Holdings Co., Ltd.

$10840
-30
 (-0.28%)
Exchange:  JPX
Market Cap:  5.703T
Shares Outstanding:  542.377M
Delayed data
Calculate 4578.T Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Drug Manufacturers – General
   
CEO:  Makoto Inoue
Full Time Employees:  35338
Address: 
2-9 Kanda-Tsukasamachi
Tokyo
101-0048
JP
Website:  https://www.otsuka.com
Otsuka Holdings Co., Ltd. is a global enterprise with operations spanning pharmaceuticals, nutraceuticals, consumer products, and various other sectors. Its pharmaceutical division is dedicated to developing treatments for a wide array of conditions, including oncology, cardiovascular, renal, and digestive system disorders, as well as ophthalmic issues. This focus also extends to diagnostic solutions, intravenous preparations, and medical devices. The company’s significant product offerings include EQUELLE, tailored for women’s health and beauty; BODYMAINTÉ Jelly and Drink, formulated as conditioning food and liquid; the popular hydration beverage POCARI SWEAT; Calorie Mate, a nutritional supplement; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a common household antiseptic. Beyond these, Otsuka’s diverse offerings encompass soft drinks, various food products, and wines. The company is involved in the production of chemicals, including pharmaceutical intermediates, industrial chemicals, hydrazine, and specialized materials such as potassium titanate, polyolefin foams, and functional films, alongside stable isotopes. It provides clinical testing apparatus, medical equipment, analysis and measurement tools, and vehicle headlight testers. Furthermore, Otsuka’s portfolio extends to cosmetics, warehousing and transport services, and advanced software for optimizing mental healthcare systems. Other products include synthetic resin molded items, paper goods, artificial turf, and a full spectrum of ceramic products—boards, walls, reliefs, terracotta, OT ceramics, portraits, and sign boards. Additionally, it offers spring and mineral water, insecticide and toiletry products, and adhesive tapes. Rounding out its operations, the company also manages a hotel. Established in 1921, Otsuka Holdings Co., Ltd. is headquartered in Tokyo, Japan.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue2,018,568,0002,329,861,0002,468,892,000
Gross Profit1,407,349,0001,669,429,0001,769,777,000
EBITDA385,366,310522,981,000611,237,000
Operating Income139,612,000396,850,000412,434,000
Net Income121,616,000343,120,000363,151,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets3,361,244,0003,739,251,0004,197,562,000
Total Liabilities924,922,000961,081,0001,097,795,000
Total Stockholders Equity2,393,683,0002,733,581,0003,033,444,000
Total Debt214,187,000189,383,000227,975,000
Cash and Cash Equivalents513,341,000426,173,000534,645,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow283,232,000354,638,000403,579,000
Capital Expenditure-90,736,000-95,558,000-87,841,000
Free Cash Flow192,496,000259,080,000315,738,000
Net Income121,616,000343,120,000363,151,000
Net Change in Cash41,707,000-87,168,000108,472,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)2,683,754,422.456Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)2,901,503,017.397Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)2,826,105,800Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)956,095,577.323Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)1,033,669,168.576Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)1,006,808,683.320Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)410,595,410.530Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)454,603,888.621Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)439,365,598.308Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)1,100,429,057.357Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,189,713,262.747Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,158,797,882.348Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)828.840Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)857.590Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)774.570Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)5Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)4Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
2.2
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
14.74
?Enterprise Value
 (TTM)
: 
5.188T  ?EV/FCF
 (TTM)
: 
16.52
?Dividend Yield
 (TTM)
: 
0.01  ?Payout Ratio
 (TTM)
: 
0.2
?ROE
 (TTM)
: 
0.13  ?ROIC
 (TTM)
: 
0.09
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.06
?P/B
 (TTM)
: 
1.79  ?Current Ratio
 (TTM)
: 
2.33

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
2,929.88Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about 4578.T valuation

Is Otsuka Holdings Co., Ltd. (4578.T) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Otsuka Holdings Co., Ltd. (4578.T) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is 4578.T a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether 4578.T trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is 4578.T’s P/E ratio?

You can see 4578.T’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for 4578.T?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is 4578.T a good long-term investment?

Whether 4578.T fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

4578.T

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.28
MARKETSnap

Trading Metrics:

Open: 10985   Previous Close: 10870
Day Low: 10810   Day High: 11010
Year Low: 6511   Year High: 11910
Price Avg 50: 10956.7   Price Avg 200: 9698.73
Volume: 792700   Average Volume: 1.194M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read